Table 1.

Tumor Biomarker Data of adjuvant patients.

Patient	Histology	T-stage	N-stage	Her2-status	Estrogen receptor (%)	Progesterone receptor (%)
Adj.1	Inv. ductal	pT2	pN3	+++	0	0
Adj.2	Inv. ductal	pT1c	pN0	++	90	90
Adj.3	Inv. ductal	pT2	pN0	-	90	90
Adj.4	Inv. lobular	pT1c	pN0	-	95	90
Adj.5	Inv. ductal	pT2	pN0	-	30	50
Adj.6	Adeno-squamous	pT3	pN0	+++	0	0
Adj.7	Inv. ductal	pT1c	pN3a	+	80	50
Adj.8	Inv. ductal	pT2	pN3a	+++	30	10
Adj.9	Inv. ductal	pT2	pN0	+	0	10
Adj.10	Inv. ductal	pT1c	pN0	++	90	60
Adj.11	Adenocarcinoma Lobular	pT2	pN1	+	80	30
Adj.12	Inv. ductal	pT2	pN0	-	90	30
Adj.13	Inv. ductal	pT2	pN0	+	80	80
Adj.14	Inv. ductal pT1c	pN0	-	0	0